Clinical manifestations of gastroesophageal reflux disease and anxiety in patients with metabolic syndrome

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Metabolic syndrome (MS) is a global medical and social concern that significantly impacts various physiological systems, including the gastrointestinal tract. One of the most common associated pathologies is gastroesophageal reflux disease (GERD). This study aimed to evaluate the severity of clinical manifestations of GERD and anxiety disorders in patients with MS. A comparative analysis was conducted between two groups: patients with combined MS and GERD, and patients with isolated GERD. The study included clinical examination, assessment using the Spielberger State-Trait Anxiety Inventory (STAI), and instrumental diagnostics. The results demonstrated higher levels of anxiety and more severe GERD symptoms in patients with MS. A statistically significant association was revealed between MS and esophageal mucosal injury.

Full Text

Restricted Access

About the authors

E. V. Shrayner

Novosibirsk State University; Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences

Author for correspondence.
Email: sch704@icloud.com
ORCID iD: 0000-0003-3606-4068
SPIN-code: 1089-6080

Candidate of Medical Sciences

Russian Federation, Novosibirsk; Novosibirsk

K. E. Kalashnikova

Novosibirsk State University

Email: sch704@icloud.com
ORCID iD: 0009-0003-2324-7102
Russian Federation, Novosibirsk

V, I. Bystrova

Novosibirsk State University; Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences

Email: sch704@icloud.com
ORCID iD: 0000-0003-3522-5384
SPIN-code: 4479-6770
Russian Federation, Novosibirsk; Novosibirsk

D. A. Lukichev

Novosibirsk State University

Email: sch704@icloud.com
ORCID iD: 0009-0000-5888-0651
Russian Federation, Novosibirsk

I. I. Smirnova

Novosibirsk State Medical University, Ministry of Health of Russia

Email: sch704@icloud.com
ORCID iD: 0009-0009-1458-1399
SPIN-code: 8992-2884
Russian Federation, Novosibirsk

A. N. Sultanova

Novosibirsk State Medical University, Ministry of Health of Russia

Email: sch704@icloud.com
ORCID iD: 0000-0001-6420-6591
SPIN-code: 5719-0860

MD

Russian Federation, Novosibirsk

D. A. Kudlay

Novosibirsk State University; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University); M.V. Lomonosov Moscow State University

Email: sch704@icloud.com
ORCID iD: 0000-0003-1878-4467
SPIN-code: 4129-7880

Professor, Corresponding Member of the Russian Academy of Sciences, MD

Russian Federation, Novosibirsk; Moscow; Moscow

References

  1. Vrdoljak J., Kumric M., Vilovic M. et al. Can Fasting Curb the Metabolic Syndrome Epidemic? Nutrients. 2022; 14: 456. doi: 10.3390/nu14030456
  2. Hsieh Y.H., Wu M.F., Yang P.Y. et al. What is the impact of metabolic syndrome and its components on reflux esophagitis? A cross-sectional study. BMC Gastroenterol. 2019; 19: 33. doi: 10.1186/s12876-019-0950-z
  3. Городецкая И.В., Коневалова Н.Ю., Захаревич В.Г. Исследование ситуативной и личностной тревожности студентов. Вестник Витебского государственного медицинского университета. 2019; 18 (5): 120–7 [Gorodetskaya I.V., Konevalova N.Y., Zakharevich V.G. The study of the situational and personal anxiety of students. Vestnik VGMU. 2019; 18 (5): 120–7 (in Russ.)]. doi: 10.22263/2312-4156.2019.5.120
  4. Zamani M., Alizadeh-Tabari S., Chan W.W. et al. Association Between Anxiety/Depression and Gastroesophageal Reflux: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2023; 118 (12): 2133–43. doi: 10.14309/ajg.0000000000002411
  5. Choi J.M., Yang J.I., Kang S.J. et al. Association Between Anxiety and Depression and Gastroesophageal Reflux Disease: Results From a Large Cross-sectional Study. J Neurogastroenterol Motil. 2018; 24 (4): 593–602. doi: 10.5056/jnm18069
  6. Ji S., Chen Y., Zhou Y. et al. Association between anxiety and metabolic syndrome: An updated systematic review and meta-analysis. Front Psychiatry. 2023; 14: 1118836. doi: 10.3389/fpsyt.2023.1118836
  7. El-Serag H.B., Sweet S., Winchester C.C. et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014; 63 (6): 871–80. doi: 10.1136/gutjnl-2012-304269
  8. Ghoshal U.C., Sonthalia N., Roy A. et al. Metabolic Syndrome and Gastroesophageal Reflux Disease: Clinical Remission with Treatment, Beyond an Epidemiological Association. J Neurogastroenterol Motil. 2025; 31 (1): 1–2. doi: 10.5056/jnm24175
  9. Gyawali C.P., Yadlapati R., Fass R. et al. Updates to the modern diagnosis of GERD: Lyon consensus 2.0. Gut. 2024; 73 (2): 361–71. doi: 10.1136/gutjnl-2023-330616
  10. Calabrese F., Pasta A., Bodini G. et al. Applying Lyon consensus criteria in the work-up of patients with extra-oesophageal symptoms – A multicentre retrospective study. Aliment Pharmacol Ther. 2024; 59 (9): 1134–43. doi: 10.1111/apt.17934
  11. Karimian M., Salamati M., Azami M. The relationship between metabolic syndrome and increased risk of Barrett's esophagus: an updated systematic review and meta-analysis. BMC Gastroenterol. 2020; 20 (1): 138. doi: 10.1186/s12876-020-01267-2
  12. Kim Y., Park J.H., Kim D.H. et al. Impact of Metabolic Health and Its Changes on Erosive Esophagitis Remission: A Cohort Study. J Neurogastroenterol Motil. 2025; 31 (1): 43–52. doi: 10.5056/jnm24058

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Reactive anxiety level in the study groups

Download (37KB)
3. Fig. 2. Level of personality anxiety in the study groups

Download (37KB)
4. Fig. 3. Endoscopy results in the study groups

Download (66KB)

Copyright (c) 2025 Russkiy Vrach Publishing House